TCM
BMY.RT

Taal Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Taal Capital Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
2020
Q3 		$788K Buy
2020
Q2 		$358K Buy